DNA replication stress: Causes, resolution and disease  by Mazouzi, Abdelghani et al.
Available online at www.sciencedirect.comjournal homepage: www.elsevier.com/locate/yexcr
E X P E R I M E N T A L C E L L R E S E A R C H 3 2 9 ( 2 0 1 4 ) 8 5 – 9 3http://dx.doi.org/10.1
0014-4827/& 2014 T
(http://creativecomm
Abbreviations: pre
7.GINS; ERFS, early-
Hutchinson–Gilford
anemia; iPOND, Iso
generation sequenc
nCorresponding au
E-mail address: jReview ArticleDNA replication stress: Causes, resolution
and diseaseAbdelghani Mazouzi, Georgia Velimezi, Joanna I. Loizoun
CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Lazarettgasse 14, AKH BT 25.3,
1090 Vienna, Austriaa r t i c l e i n f o r m a t i o n
Article Chronology:
Received 30 May 2014
Received in revised form
20 September 2014
Accepted 22 September 2014
Available online 30 September 2014
Keywords:
DNA replication
DNA damage signaling
Replication stress
Genome stability
Chromosome fragile sites016/j.yexcr.2014.09.030
he Authors. Published by E
ons.org/licenses/by-nc-nd
-RC, pre-replicative comp
replicating fragile site; D
progeria syndrome; SIO
lation of protein on nasc
ing; CRISPR, Clustered re
thor. Fax: þ43 1 40160 970
loizou@cemm.oeaw.ac.at (a b s t r a c t
DNA replication is a fundamental process of the cell that ensures accurate duplication of the
genetic information and subsequent transfer to daughter cells. Various pertubations, originating
from endogenous or exogenous sources, can interfere with proper progression and completion of
the replication process, thus threatening genome integrity. Coordinated regulation of replication
and the DNA damage response is therefore fundamental to counteract these challenges and
ensure accurate synthesis of the genetic material under conditions of replication stress. In this
review, we summarize the main sources of replication stress and the DNA damage signaling
pathways that are activated in order to preserve genome integrity during DNA replication. We
also discuss the association of replication stress and DNA damage in human disease and future
perspectives in the ﬁeld.
& 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-
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Several exogenous and endogenous sources constantly challenge
the integrity of replicating DNA, and can pose a serious threat to
chromosomal stability by interfering with progression, stability
and proper resumption of replication after fork arrest. DNA
damage generated endogenously by errors during DNA replication
is often referred to as replication stress and particularly affects
genomic loci where progression of replication forks is slow or
problematic. Cells have evolved a panoply of mechanisms to deal
with different kinds of DNA damage that ensure the integrity of
the genome during replication. Various repair mechanisms and
different checkpoint machineries exist, which stop or slow down
cell cycle progression until the damage is repaired. These DNA
replication, repair and checkpoint activation pathways are highly
regulated and coordinated. Defects in any of these functions leads
to genomic instability and may lead to cancer, premature ageing
or disorders associated with loss of genomic integrity.Overview of DNA replication
DNA replication is initiated at deﬁned loci known as replication
origins. In the eukaryotic genome, replication begins at multiple
origins, ranging from a few hundred in yeast to thousands in
humans. These are distributed along the length of each chromo-
some [1]. Initiation of replication comprises a two-step process:
origin licensing and ﬁring. Origin licensing starts as early as late M
or early G1 with the assembly of a pre-replicative complex (pre-
RC) at each origin (early or late). The pre-RC consists of the origin
recognition complex (ORC1–6 proteins), cell division cycle 6
(Cdc6), cell division cycle 10-dependent transcript 1 (Cdt1) and
the core replicative helicase component Mcm2–7, consisting of
the minichromosome maintenance proteins 2–7 (Mcm2–Mcm7)
[2,3]. The second step, origin ﬁring, involves the activation of the
Mcm2–7 complex which is restricted to S phase and culminates in
the formation of a pair of oppositely oriented replication forks
that contain a single Mcm2–7 helicase hexamer complex at the
apex of each fork [4]. Cyclin dependent kinases (CDKs) and Dbf
dependent kinases (DDKs) promote the conversion of the pre-RC
complex into a pre-initiation complex capable of unwinding DNA
and carrying out DNA synthesis [5]. At the G1/S transition, when
CDK activity rises, numerous additional factors cooperate to
convert the MCM2–7 double hexamer into two CMG (Cdc45.
Mcm2–7.GINS) complexes [6]. In particular, Cdc7–Dbf4 protein
kinase (DDK) phosphorylates MCM2–7. CDK phosphorylates Sld2
(sharing homology to human RECQ4) and Sld3 (the yeast homo-
log of Treslin in human), promoting their interaction with Dpb11
(the yeast homolog of TopBP1 in human). The Sld3–Sld2–Dpb11
complex enables the stable binding of Cdc45 and GINS to
phosphorylated MCM2–7. Once formed, CMG unwinds the origin,allowing replisome assembly. Replication forks then travel bidir-
ectionally outwards from the origin until the entire genome is
replicated [7–10].Sources of DNA replication stress
Replication stress is deﬁned as slowing or stalling in replication
fork progression. It arises from many different sources, which are
considered as replication barriers such as telomeres, repetitive
sequences, DNA lesions and misincorporation of ribonucleotides,
secondary DNA structures, DNA–RNA hybrids, dormant replica-
tion origins, collisions between replication and transcription
complexes, hypo-acetylation and compaction of chromatin,
early-replicating fragile sites (ERFSs) and common fragile sites
(CFSs). Finally overexpression or constitutive activation of onco-
genes such as HRAS, c-Myc and cyclin E is an emerging source of
replication stress. Following, we discuss some of the most
relevant sources of replication stress in more detail (see Fig. 1).
We refer readers to the following review for an overall picture of
agents than induce replication stress [11].
Fragile sites
Certain loci in the human genome are particularly difﬁcult to
replicate, hence rendering them prone to fragility. Most promi-
nent amongst these are the so-called fragile site loci. As men-
tioned above, fragile sites can be classed CFSs or ERFSs. The
former have a high A/T content, occur at sequences prone to form
secondary structures, possess a condensed chromatin structure
and replicate late. In contrast ERFSs are G/C rich, have an open
chromatin state and replicate early.
Fragile sites are deﬁned as being either common or rare; the
former, CFSs, are present in all individuals, whereas rare fragile
sites are found in less than 5% of the population [12]. There are
over 200 CFSs in the human genome and these regions are quite
large, ranging from just under 1 Mb to over 10 Mb in size. CFSs are
prone to replication stress-induced DNA double-strand breaks
(DSBs) visible in condensed metaphase chromosomes and their
occurrence is dependent on the endonuclease activity of MUS81-
EME1, in synergy with the resolving action of the BLM helicase to
prevent chromosome breakage [13,14]. The most typical inducer
of CFSs used experimentally is aphidicolin, an inhibitor of the
replicative DNA polymerases α, δ, and ε [15]. The three most
frequently expressed CFSs are FRA3B, FRA16D, and FRA6E [16–18].
Several studies in cell culture models have shown that under
conditions that induce replication stress, fragile sites are hotspots
for sister chromatid exchange, translocations and deletions [19].
The frequent alterations within these regions in multiple cancers
have led to the identiﬁcation of a number of extremely large
genes contained within CFSs. Several of these large genes have
Fig. 1 – Schematic representation of the predominant DNA damage pathways that process replication intermediates. Replication
stress induced by various endogenous or exogenous sources results in the generation of single strand DNA bound by RPA protein.
RPA recruits ATRIP, Rad17 and 9-1-1 complex which together with TOPBP1 result in the activation of the ATR kinase, which is
responsible for phosphorylation of CHK1, suppression of new origin ﬁring and activation of the S phase checkpoint, allowing time
for the cell to recover. The MRN complex and RAD51 have also been shown to be recruited at sites of single strand DNA after
replication stress and to be required for fork restart. While it is unclear whether ATM has a role in MRN activation under these
conditions, ATMIN, which is also an interactor of ATM, may play a role in ATM activation in response to replication stress. ATM can
also activate BLM helicase which contributes to the resolution of replication intermediates. When the ATR pathway is
compromised, defective checkpoint activation may result to the collapse of the replication fork into double strand breaks which
then may be resolved by homologous recombination through recruitment of CtIP and RAD51. However, in the absence of ATR,
replication stress can leave regions of the genome incompletely replicated resulting in abnormal DNA structures which if not
properly resolved can be transmitted to the next generation in the form of DNA lesions resulting in genome instability.
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the formation of many different cancers including colorectal
cancer and oropharyngeal squamous cell carcinomas [20–22].
A recent concept emphasizes the importance of replication origin
density in the maintenance of CFS stability [23]. According to this
concept, certain common fragile sites are characterized by a
reduced number of replication initiation events that limit the
number and density of active origins, thus rendering these
“initiation-poor” regions susceptible to incomplete replication
and fragility.
ERFSs are a new class of fragile sites and have been deﬁned as
similar to CFSs. This is because of their susceptibility to chromo-
some breakage, dependence on ATR signaling and sensitivity to
replication stress induced by hydroxyurea, ATR inhibition or
deregulated c-Myc expression. Moreover, more than 50% of
recurrent ampliﬁcations/deletions in human diffuse large B cell
lymphoma map to ERFSs [24].
Replication–transcription complex collision
Collisions between transcription machinery and replication forks
are an additional source of genome instability. In higher eukar-
yotes, replication and transcription are coordinated processes, and
they occur within spatially and temporally separated domains.
Active transcription usually occurs in the G1 phase. When
transcription occurs in S phase, it has been suggested to be
spatially separated from replication sites [25]. It has been
reported that genes of 800 Kb or more in size, often located at
CFSs, produce their transcripts over more than one cell cycle,
consequently extending transcription into the next S phase, which
increases the probability of collisions between replication and
transcription complexes and hence formation of DNA–RNA
hybrids (R-loops). Multiple strategies are employed to avoid R-
loop formation in prokaryotic and eukaryotic cells. Helmrich and
colleagues and Wahba and colleagues demonstrate in vivo roles
for RNaseH enzymes in maintaining genome integrity, which has
potential implications in human disease (see section on diseases
associated with defective clearance of replication stress) [26,27].
Interestingly, a recent study showed that BRCA2, a DNA repair
protein with tumor suppressive function prevents accumulation
of R-loops [28]. Although the exact mechanism is unclear, this
important ﬁnding further demonstrates the essential role of DNA
damage and repair components for efﬁcient dealing with replica-
tion stress. Apart from the generation of R-loops transcription can
interfere with replication by imposing increased topological stress
at sites where newly formed RNA transcripts are tethered to
nuclear pore complexes for further processing. Bermejo et al.
showed that the ATR-dependent checkpoint counteracts this
topological stress by releasing transcribed genes from the nuclear
pores, allowing normal progression of the replication fork [29]
Oncogenic stress
Oncogenic stress is a major driving force in the early stages of
cancer development [30]. The ﬁnding that DNA damage response
is activated in hyperplastic tissues and after overexpression of
oncogenes such as cyclin E, cdc25A and E2F1 (that deregulate
replication) set the ground for linking oncogenes to replication
stress-associated DNA damage [31,32]. In studies that followed,
further analysis of replication dynamics and the DNA damageresponse after overexpression of oncogenes conﬁrmed this model,
where oncogenes such as cyclin E lead to perturbation of normal
replication, activation of the DNA damage response and cell cycle
checkpoints that lead to arrest or senescence [33,34]. Cyclin E
causes replication stress not only by deregulating cell cycle
progression but also by disrupting DNA replication during S
phase. Cyclin E overexpression is associated with increased ﬁring
of replication origins, impaired replication fork progression and
DNA damage. A signiﬁcant amount of Cyclin E-induced replication
slowing is due to decreased nucleotide pools and/or interference
between replication and transcription. c-Myc is another oncogene
found to directly control DNA synthesis and promotes cell
proliferation. Indeed, overexpression studies have indicated that
ectopic expression or conditional activation of c-Myc triggers an
increase in the percentage of S phase cells in asynchronous
populations [35]. The overexpression of c-Myc in a number of in
vitro cellular systems has been associated with the activation of a
DNA damage response (DDR), and increased genomic instability
[36,37]. This suggests that elevated c-Myc levels lead to the
accumulation of DNA damage, however the molecular mechanism
is still not completely deﬁned. One of the suggested mechanisms
c-Myc induced genomic instability is its affect on replication fork
dynamics [38]. It has been shown that elevated levels of c-Myc
increase the number of ﬁring replication origins which are highly
asymmetric. This can lead to uneven replication processivity on
either side of the replication bubble, which is indicative of
replication stress and fork stalling events [35].
DNA structures
It is thought that the accessibility of DNA to replication factors can
be inﬂuenced by local chromatin structure. Additionally, chroma-
tin structure modulates origin ﬁring time and efﬁciency [39].
The canonical DNA structure is the right-handed double helix B
form of DNA. However, it can adopt several other non-B DNA
structures including: cruciforms, hairpins, H DNA, Z DNA and G4.
These secondary conformations form in the genome at speciﬁc
DNA repetitive sequences and present a challenge for progression
of DNA replication forks. Impeding normal DNA synthesis, and
formation of these alternative forms of DNA structure may threat
genome stability and in some instances play a causal role in
disease development [40].The kinases ATR and ATM signal DNA replication
stress
In order to cope with the constant challenge of DNA damage
encountered by replicating DNA, cells activate a complex network
of interacting pathways that lead either to the repair of the
damage and resumption of normal cell cycle progression or to
programmed cell death. This network coordinates the activation
of cell cycle checkpoints, the appropriate DNA repair pathways,
and numerous other responses [41]. One of the central compo-
nents of the DDR is the serine–threonine kinase Ataxia Telan-
giectasia Mutated protein (ATM), which phosphorylates
numerous key players in various branches of the DDR [42,43].
ATM is a member of the phosphoinositide 3-kinase (PI3K)-related
protein kinase (PIKK) family, which also includes Ataxia Telan-
giectasia and Rad3 Related protein (ATR) – refer to Fig. 1. ATM
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DNA DSBs. In contrast, ATR is the key kinase in signaling the
response to ssDNA, which can occur at persistent DSBs, but more
extensively on stalled replication forks [44].
Functions of ATR
ATR is activated by its physical recruitment to the ss-DNA binding
protein RPA, which independently brings together the two
components of the ATR pathway. On one hand, RPA recruits
ATRIP, which is in a complex with ATR and thus brings the kinase
to the DNA lesion. On the other hand, RPA recruits Rad17, which
loads the Rad9–Hus1–Rad1 (9-1-1) complex. This complex is then
essential to recruit and position the allosteric activator TopBP1.
Within close proximity, TopBP1 activates ATR. In spite of the
numerous substrates of ATR, the key event that translates ATR
activity into a checkpoint signal may mostly depend on one single
target, which is the phosphorylation and activation of CHK1 [44].
ATR and/or CHK1 inhibition results in checkpoint defects and
chromosome breakage, further consolidating the notion that cell-
cycle checkpoints somehow prevent uncontrolled fork collapse
[45]. However, the mechanism governing global regulation of
checkpoints via inhibition of new DNA replication origins from
ﬁring by the ATR/CHK1 pathway to maintain local fork stability
remains unclear. There are two possible mechanisms, ﬁrstly
checkpoint signaling locally affects replication fork components,
which would contribute directly to fork stabilization. Secondly,
ATR signaling regulates recombinational repair, which is neces-
sary to restart collapsed forks. Toledo and colleagues demon-
strated another mechanism, which explains how ATR protects
replication forks locally and suppresses origin ﬁring globally.
When ATR is activated by RPA-coated ssDNA generated ahead of
the stalled replication fork, CHK1 diffuses globally through the
nucleus, where it inhibits new origin ﬁring [46]. This ensures that
RPA remains in excess over ssDNA by limiting the number of
stalled forks to those that were originally active at the onset of the
replication stress. If ATR signaling fails, dormant origins ﬁre, and
the newly generated ssDNA progressively depletes nuclear RPA.
When all RPA becomes sequestered, every active replicon gen-
erates unprotected ssDNA, which is rapidly converted into DSBs
[45,46]. Recently, Yamada et al. showed that in human cells
activation of the ATR/CHK1 pathway results in stabilization of
chromatin-bound Cdc7–ASK kinase complex (human homolog of
cdc7–Dbf4) which is necessary for initiation of normal replication
and origin ﬁring [47]. However, upon staling of replication,
activation of cdc7/ASK complex by the ATR/CHK1 pathway is
required for efﬁcient lesion bypass repair, thus preventing fork
collapse under conditions of replication stress.
Functions of ATM
Although ATR is considered to be the major kinase mediating the
response to replication stress, mainly due to its ability to activate
the intra-S phase checkpoint, evidence exists to support a role for
ATM activation in response to replication stress. One aspect of
ATM function under these conditions could be the activation of
the homologous recombination repair pathway, which is impor-
tant for restart of collapsed replication forks and recovery of
replication after induction of replication stress [48]. This function
may require the recruitment of the MRN complex at sites ofstalled or collapsed replication forks that promote DNA end-
resection, the ﬁrst important step for homologous recombination.
Recruitment of the MRN complex to sites of DNA damage is
important for ATM activation in response to ionizing radiation
(IR)-induced DSBs. The MRN complex members Mre11 and Nbs1
are required for efﬁcient recovery of replication after treatment
with replication stalling agents such as hydroxyurea [49,50].
However, the necessity for an interaction between ATM and
Mre11 and Nbs1 at sites of stalled forks remains a matter of
controversy. Certain studies indicate that recruitment of the MRN
complex following replication stress contributes to activation of
ATR rather than ATM signaling [51–53]. However, another study
suggests that both ATM and ATR are required for efﬁcient Mre11-
dependent fork restart and prevention of DSB accumulation
during unperturbed replication and after chemically induced
replication stress [54]. Apart from homologous recombination,
ATM can also inﬂuence replication fork restart by directly
regulating the DNA helicases WRN and BLM, which are both
required for resolution of replication intermediates and are both
substrates of ATM [55,56].
Two independent studies show that activated ATM is recruited
to chromatin foci at sites of common fragile sites following mild
replication stress induced by aphidicolin [57,58]. In line with this,
ATM depletion in addition to ATR loss results in increased fragility
at CFS compared to depletion of ATR alone, supporting a role for
ATM in the maintenance of chromosome stability after replication
stress [59]. According to the proposed model, ATM is activated
after formation of DNA DSBs that arise at a later stage as a result
of replication fork collapse or chromatin breakage at sites of
unreplicated DNA during mitosis. If the role of ATM is restricted
solely to the activation of checkpoint and DNA repair in response
to DSBs that arise as a result of further processing of replication
intermediates remains unclear. Evidence challenging this view is
limited, nevertheless intriguing, especially considering the lack of
information on the exact nature of the speciﬁc DNA lesions that
arise at sites of stalled forks and incompletely replicated DNA.
For example, induction of replication stress by low doses of the
topoisomerase I inhibitor camptothecin results in ATM activation
in the absence of detectable DSBs [60]. Furthermore recent data
from a large-scale analysis of proteins speciﬁcally localized at
stalled forks after replication stress showed ATM recruitment at
nascent chromatin at an early stage of DNA replication [61].
However, a role for ATM in the early response to replication stress
has not been conﬁrmed and more studies will be needed to clarify
this. Moreover, the type, intensity and duration of the stimulus
might be critical factors determining the relative contribution of
each pathway to the ﬁnal response.
In addition to NBS1, ATM possesses a second cofactor; ATMIN
(also known as ASCIZ) that has been described [62,63]. ATMIN
interacts with ATM using a motif homologous to that of NBS1
[62]. It has previously been shown using siRNA approaches in
human cell lines and using ATMIN-deﬁcient mouse embryonic
ﬁbroblasts (MEFs) that ATMIN has a complementary function to
NBS1 with respect to ATM activation: ATMIN is dispensable for IR-
induced ATM signaling, but ATM activation following replication
and hypotonic stress is mediated by ATMIN [62]. Hence, NBS1 and
ATMIN are required for ATM activation in a signal dependent
manner [64].
Unresolved replication intermediates can occur during S/G2
phases of the cell cycle and can be converted into DNA lesions in
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that binds to p53, known as 53BP1 [65], is involved in shielding
genomic regions exposed to replication stress and is recruited to
such sites in an ATM-dependent manner. 53BP1 forms nuclear
bodies at such sites of unrepaired DNA lesions in the subsequent
G1 phase to shield these regions against erosion [58].Defects in resolving DNA replication stress:
implications in human disease
Identiﬁcation of mutations responsible for various genetic syn-
dromes has revealed the direct implication of proteins mediating
the response to replication stress in the pathology of human
disease [11]. Phenotypic characteristics shared among these
syndromes include developmental defects, growth retardation
and neurological disorders, suggestive for the importance of
efﬁcient regulation of replication during processes that require
increased cell proliferation. For example, mutations in the pre-
replication factors ORC1, ORC2–6 and cdt1, cdc6 that affect
licensing of DNA replication are related to the Meier–Gorlin
Syndrome, a disease characterized by severe growth retardation
and developmental malformations [66].
Many other mutations involved in genetic syndromes affect
proteins that also play an important role in the DDR, which is
essential for accurate replication of the genetic material. The most
prominent example is the Seckel syndrome caused predominantly
by mutations in the ATR gene, which is essential for the activation
of the intra-S phase checkpoint during replication stress [67].
Interestingly, a different type of Seckel syndrome is associated
with mutations found in the RBBP8 gene encoding CtIP, a protein
required for DNA-end resection during S phase [68]. More
importantly, CtIP is an ATM substrate and interacts with the
MRN complex, which also mediates DNA damage signaling and
repair during replication. Mutations affecting members of the
MRN complex cause syndromes characterized by growth and
developmental defects [69]. Apart from ATR and RBBP8, other
types of Seckel syndrome are caused by mutations in genes
affecting centrosome structure and function including pericentrin
(PCNT) [70].
Another type of heterogeneous human diseases, collectively
called laminopathies, are the result of mutations in nuclear lamin
genes such as LMNA which lead to abnormal nuclear morphology
and alterations in chromatin structure. Interestingly, cells expres-
sing a defective form of Lamin A called progerin are more
sensitive to replication stress and recently it has been demon-
strated that reorganization of the microtubule network inside the
nucleus can rescue the nuclear morphology and ﬁtness of
laminopathic cells derived from Hutchinson–Gilford progeria
syndrome (HGPS) patients [71,72]. The above examples provide
a link between microtubule network organization and replication
stress and point out the importance of intact centrosome function
and nuclear structure for normal replication.
Mutations in proteins involved in chromatin remodeling during
DNA replication have also been associated with human disease.
Mutations in the SMARCAL1 and ATRX genes, which are both
related to the SWI–SNF chromatin remodeling complex, are
mutated in the Schimke immune-osseous dysplasia (SIOD) and
the α-thalassemia/mental retardation syndrome, X-linked (ATR-X)
respectively [73,74].Hypomorphic mutations in the RNase H2 gene cause the
Aicardi-Goutieres syndrome that is characterized by severe neu-
rological dysfunction and a congenital infection-like phenotype
[75]. As RNase H2 cleaves misincorporated ribonucleotides and
DNA:RNA hybrids that arise during replication, it is possible that a
defective response to increased replication stress may be the
cause of the developmental retardation phenotype. Another
protein acting in the same pathway, aprataxin (APTX) is mutated
in the neurological disorder Apraxia Oculomotor Ataxia 1 (AOA1),
characterized by cerebellar degeneration. Aprataxin deadenylates
adenylated RNA:DNA hybrids that arise after cleavage by RNase
H2, thus preventing S phase checkpoint activation [76].
Mutations in the FA complementation group are responsible for
the heterogeneous genetic disorder Fanconi Anemia (FA) which is
characterized by skeletal abnormalities, developmental delay,
growth retardation and increased incidence of cancer develop-
ment, especially in tissues with a high proliferation index [77].
FA proteins are components of the interstrand crosslink DNA
repair pathway, while FANCD2 is also essential for maintenance of
genome stability during replication [78]. Mutations affecting the
RECQ family DNA helicases WRN, BLM and RECQL4, which play an
important role in the efﬁcient resolution of replication intermedi-
ates and arrested forks, are responsible for the genetic syndromes
Werner, Bloom and Rothmund–Thomson respectively [79].
In addition to growth retardation, these syndromes are also
characterized by premature aging and predisposition to cancer,
phenotypes indicative of increased genomic instability. Cancer
susceptibility is also a characteristic of FA patients suggesting a
causative link between replication stress and cancer. Conﬁrming
this link, replication stress has been shown to be a major source of
chromosomal instability (CIN) observed in CINþ colorectal cancers
[80].
Whether replication stress is a driving force of tumourigenesis
or a result of oncogenic mutations that allows further genome
instability during cancer development remains to be elucidated.
Interestingly, extensive crosstalk between different DNA repair
pathways is necessary for the coordination of an efﬁcient
response to replication stress. For example, FANCD2 has been
shown to mediate part of the ATR response to replication stress,
while it also interacts with CtIP and BLM to promote restart of
stalled replication forks [81–83]. Although the exact mechanism
of the pathological phenotype is not entirely understood, com-
mon clinical manifestations of mutations in different genes of
these pathways clearly indicates the existing crosstalk and the
need for efﬁcient coordination of the replication process with the
DNA repair machinery through the DNA damage signaling path-
way in order to allow normal progression of DNA replication
while preserving genome integrity.Conclusions and perspectives
Elucidating the pathways and interactions governing the response
to replication stress will shed light on the molecular mechanisms
that ensure genome integrity during replication under endogen-
ous sources of replication stress. Furthermore, we will increase
our understanding of how exogenous sources or defects in critical
pathway components can lead to increased genome instability.
An important challenge for the years to come will be to identify
the speciﬁc regions of the genome that are particularly affected
E X P E R I M E N T A L C E L L R E S E A R C H 3 2 9 ( 2 0 1 4 ) 8 5 – 9 3 91during different types of replication stress. To this end, recent
advances in technology can be exploited to apply novel metho-
dology such as next generation sequencing, iPOND or BLESS to
map speciﬁc DNA regions affected by replication stress and the
speciﬁc protein interactions that mediate their fragility, respec-
tively [84,85]. Moreover, CRISPR-mediated imaging of speciﬁc
chromatin loci in living cells offers a powerful opportunity to
reveal the dynamic interactions at sites of increased fragility
following replication stress [86]. Thus, despite the progress that
has been achieved during the last years, extensive studies and
novel technology will be needed to boost our current under-
standing of the mechanisms mediating the response to replication
stress and the associated genome instability. Advance in current
knowledge regarding the response to replication stress will also
be an important step towards more specialized therapies and
development of new treatments for diseases including cancer.Conﬂict of interest
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